PG
EW icon

PEAK6 Group’s Edwards Lifesciences EW Stock Holding History

PEAK6 Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$946K Sell
19,500
-436,800
-96% -$20.4M ﹤0.01% 2007
2018
Q1 		$21.2M Buy
456,300
+69,000
+18% +$3M 0.09% 213
2017
Q4 		$14.6M Buy
+387,300
New +$14.2M 0.07% 324
2017
Q3 		– Sell
-10,200
Closed -$402K – 4554
2017
Q2 		$402K Sell
10,200
-38,700
-79% -$1.41M ﹤0.01% 2735
2017
Q1 		$1.53M Buy
48,900
+40,800
+504% +$1.28M 0.01% 1342
2016
Q4 		$253K Sell
8,100
-46,200
-85% -$1.5M ﹤0.01% 3141
2016
Q3 		$2.18M Sell
54,300
-57,300
-51% -$2.16M 0.02% 1221
2016
Q2 		$3.71M Buy
111,600
+39,000
+54% +$1.33M 0.03% 846
2016
Q1 		$2.13M Sell
72,600
-33,600
-32% -$927K 0.02% 1121
2015
Q4 		$2.8M Buy
106,200
+27,000
+34% +$701K 0.02% 1088
2015
Q3 		$1.88M Sell
79,200
-121,800
-61% -$2.94M 0.01% 1629
2015
Q2 		$4.77M Sell
201,000
-136,200
-40% -$3.07M 0.03% 865
2015
Q1 		$8.01M Buy
337,200
+17,400
+5% +$390K 0.06% 422
2014
Q4 		$6.79M Sell
319,800
-141,600
-31% -$2.84M 0.05% 478
2014
Q3 		$7.86M Buy
461,400
+163,200
+55% +$2.58M 0.06% 410
2014
Q2 		$4.27M Buy
298,200
+240,000
+412% +$3.25M 0.04% 617
2014
Q1 		$719K Buy
58,200
+54,600
+1,517% +$630K 0.01% 2174
2013
Q4 		$39K Sell
3,600
-685,200
-99% -$7.72M ﹤0.01% 4419
2013
Q3 		$4M Buy
688,800
+178,200
+35% +$2.08M 0.03% 950
2013
Q2 		$5.72K Buy
+510,600
New +$6.04M 0.02% 652

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Group's EW Position: Q2 2018 in Review

PEAK6 Group opened a new position in Edwards Lifesciences (EW) in Q2 2018: 5,466 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #3133 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in EW as recently as Q3 2017.

PEAK6 Group first reported a position in EW in Q2 2013 and has held it in 14 quarters since. The position peaked at $9.51M in Q4 2016. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

  • PEAK6 Group held 5,466 shares of Edwards Lifesciences worth $265K as of Q2 2018.
  • Edwards Lifesciences was a new PEAK6 Group position in Q2 2018.
  • Edwards Lifesciences made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3133 holding.
  • PEAK6 Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 14 quarters since.
  • PEAK6 Group's Edwards Lifesciences position peaked at $9.51M in Q4 2016.
  • 838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.